QNTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Quantum Biopharma Ltd (QNTM) is not a good buy for a beginner, long-term investor at this time. The company shows weak financial performance, no significant positive catalysts, and bearish technical indicators. Additionally, there are no strong proprietary trading signals to suggest a compelling entry point.
The technical indicators are bearish. The MACD is above 0 but contracting, RSI is neutral at 39.43, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 3.693, with key support at 3.468 and resistance at 3.919.
No significant positive catalysts identified. No recent news, no insider or hedge fund activity, and no congress trading data.
Weak financial performance with negative EPS (-1.4, down 67.96% YoY), negative net income (-$5,319,029), and no revenue growth. The stock also has a low market cap of $13.64M, indicating limited investor confidence.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$5,319,029 (up 32.47% YoY), and a significant EPS decline to -1.4 (-67.96% YoY). Gross margin remains at 0%.
No analyst ratings or price target changes available for QNTM.
